343 related articles for article (PubMed ID: 33066024)
1. High Cysteinyl Leukotriene Receptor 1 Expression Correlates with Poor Survival of Uveal Melanoma Patients and Cognate Antagonist Drugs Modulate the Growth, Cancer Secretome, and Metabolism of Uveal Melanoma Cells.
Slater K; Heeran AB; Garcia-Mulero S; Kalirai H; Sanz-Pamplona R; Rahman A; Al-Attar N; Helmi M; O'Connell F; Bosch R; Portela A; Villanueva A; Gallagher WM; Jensen LD; Piulats JM; Coupland SE; O'Sullivan J; Kennedy BN
Cancers (Basel); 2020 Oct; 12(10):. PubMed ID: 33066024
[TBL] [Abstract][Full Text] [Related]
2. 1,4-dihydroxy quininib modulates the secretome of uveal melanoma tumour explants and a marker of oxidative phosphorylation in a metastatic xenograft model.
Slater K; Bosch R; Smith KF; Jahangir CA; Garcia-Mulero S; Rahman A; O'Connell F; Piulats JM; O'Neill V; Horgan N; Coupland SE; O'Sullivan J; Gallagher WM; Villanueva A; Kennedy BN
Front Med (Lausanne); 2022; 9():1036322. PubMed ID: 36698840
[TBL] [Abstract][Full Text] [Related]
3. 1,4-dihydroxy quininib activates ferroptosis pathways in metastatic uveal melanoma and reveals a novel prognostic biomarker signature.
Tonelotto V; Costa-Garcia M; O'Reilly E; Smith KF; Slater K; Dillon ET; Pendino M; Higgins C; Sist P; Bosch R; Passamonti S; Piulats JM; Villanueva A; Tramer F; Vanella L; Carey M; Kennedy BN
Cell Death Discov; 2024 Feb; 10(1):70. PubMed ID: 38341410
[TBL] [Abstract][Full Text] [Related]
4. Ergolide mediates anti-cancer effects on metastatic uveal melanoma cells and modulates their cellular and extracellular vesicle proteomes.
Sundaramurthi H; Tonelotto V; Wynne K; O'Connell F; O'Reilly E; Costa-Garcia M; Kovácsházi C; Kittel A; Marcone S; Blanco A; Pallinger E; Hambalkó S; Piulats Rodriguez JM; Ferdinandy P; O'Sullivan J; Matallanas D; Jensen LD; Giricz Z; Kennedy BN
Open Res Eur; 2023; 3():88. PubMed ID: 37981907
[TBL] [Abstract][Full Text] [Related]
5. A Quininib Analogue and Cysteinyl Leukotriene Receptor Antagonist Inhibits Vascular Endothelial Growth Factor (VEGF)-independent Angiogenesis and Exerts an Additive Antiangiogenic Response with Bevacizumab.
Butler CT; Reynolds AL; Tosetto M; Dillon ET; Guiry PJ; Cagney G; O'Sullivan J; Kennedy BN
J Biol Chem; 2017 Mar; 292(9):3552-3567. PubMed ID: 28035003
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of oncogenic cysteinyl leukotriene receptor 2 as a therapeutic target for uveal melanoma.
Slater K; Hoo PS; Buckley AM; Piulats JM; Villanueva A; Portela A; Kennedy BN
Cancer Metastasis Rev; 2018 Sep; 37(2-3):335-345. PubMed ID: 30094568
[TBL] [Abstract][Full Text] [Related]
7. DNA Methylation and Gene Expression of the Cysteinyl Leukotriene Receptors as a Prognostic and Metastatic Factor for Colorectal Cancer Patients.
Ghatak S; Satapathy SR; Sjölander A
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36834820
[TBL] [Abstract][Full Text] [Related]
8. Discovery and Development of the Quininib Series of Ocular Drugs.
Mahon N; Slater K; O'Brien J; Alvarez Y; Reynolds A; Kennedy B
J Ocul Pharmacol Ther; 2022; 38(1):33-42. PubMed ID: 35089801
[TBL] [Abstract][Full Text] [Related]
9. Modeling of human uveal melanoma in zebrafish xenograft embryos.
van der Ent W; Burrello C; Teunisse AF; Ksander BR; van der Velden PA; Jager MJ; Jochemsen AG; Snaar-Jagalska BE
Invest Ophthalmol Vis Sci; 2014 Sep; 55(10):6612-22. PubMed ID: 25249605
[TBL] [Abstract][Full Text] [Related]
10. Functional characterisation of receptors for cysteinyl leukotrienes in smooth muscle.
Jonsson EW
Acta Physiol Scand Suppl; 1998 Mar; 641():1-55. PubMed ID: 9597121
[TBL] [Abstract][Full Text] [Related]
11. Mitochondrial DNA polymorphisms and biogenesis genes in primary and metastatic uveal melanoma cell lines.
Singh L; Atilano SR; Jager MJ; Kenney MC
Cancer Genet; 2021 Aug; 256-257():91-99. PubMed ID: 34082186
[TBL] [Abstract][Full Text] [Related]
12. The immune cell landscape of metastatic uveal melanoma correlates with overall survival.
Tosi A; Cappellesso R; Dei Tos AP; Rossi V; Aliberti C; Pigozzo J; Fabozzi A; Sbaraglia M; Blandamura S; Del Bianco P; Chiarion-Sileni V; Rosato A
J Exp Clin Cancer Res; 2021 May; 40(1):154. PubMed ID: 33947438
[TBL] [Abstract][Full Text] [Related]
13. Uveal melanoma modeling in mice and zebrafish.
van den Bosch QCC; de Klein A; Verdijk RM; Kiliç E; Brosens E;
Biochim Biophys Acta Rev Cancer; 2024 Jan; 1879(1):189055. PubMed ID: 38104908
[TBL] [Abstract][Full Text] [Related]
14. In-depth proteomic profiling of the uveal melanoma secretome.
Angi M; Kalirai H; Prendergast S; Simpson D; Hammond DE; Madigan MC; Beynon RJ; Coupland SE
Oncotarget; 2016 Aug; 7(31):49623-49635. PubMed ID: 27391064
[TBL] [Abstract][Full Text] [Related]
15. 1,4-dihydroxy quininib attenuates growth of colorectal cancer cells and xenografts and regulates the TIE-2 signaling pathway in patient tumours.
Butler CT; Kennedy SA; Buckley A; Doyle R; Conroy E; Gallagher WM; O'Sullivan J; Kennedy BN
Oncotarget; 2019 Jun; 10(38):3725-3744. PubMed ID: 31217905
[TBL] [Abstract][Full Text] [Related]
16. The Autocrine FGF/FGFR System in both Skin and Uveal Melanoma: FGF Trapping as a Possible Therapeutic Approach.
Rezzola S; Ronca R; Loda A; Nawaz MI; Tobia C; Paganini G; Maccarinelli F; Giacomini A; Semeraro F; Mor M; Presta M
Cancers (Basel); 2019 Sep; 11(9):. PubMed ID: 31487962
[TBL] [Abstract][Full Text] [Related]
17. PRAME as a Potential Target for Immunotherapy in Metastatic Uveal Melanoma.
Gezgin G; Luk SJ; Cao J; Dogrusöz M; van der Steen DM; Hagedoorn RS; Krijgsman D; van der Velden PA; Field MG; Luyten GPM; Szuhai K; Harbour JW; Jordanova ES; Heemskerk MHM; Jager MJ
JAMA Ophthalmol; 2017 Jun; 135(6):541-549. PubMed ID: 28448663
[TBL] [Abstract][Full Text] [Related]
18. Expression of the serotonin receptor 2B in uveal melanoma and effects of an antagonist on cell lines.
Weidmann C; Bérubé J; Piquet L; de la Fouchardière A; Landreville S
Clin Exp Metastasis; 2018 Mar; 35(3):123-134. PubMed ID: 29696577
[TBL] [Abstract][Full Text] [Related]
19. Vascular endothelial growth factor expression and inhibition in uveal melanoma cell lines.
Logan P; Burnier J; Burnier MN
Ecancermedicalscience; 2013; 7():336. PubMed ID: 23914254
[TBL] [Abstract][Full Text] [Related]
20. c-Met, epidermal growth factor receptor, and insulin-like growth factor-1 receptor are important for growth in uveal melanoma and independently contribute to migration and metastatic potential.
Wu X; Zhou J; Rogers AM; Jänne PA; Benedettini E; Loda M; Hodi FS
Melanoma Res; 2012 Apr; 22(2):123-32. PubMed ID: 22343486
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
